Surge In Livestock Population Drives Growth In The Foot And Mouth Disease Vaccine Market Emerges as a Core Driver of the Foot And Mouth Disease Vaccine Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Foot And Mouth Disease Vaccine Market Through 2025?
In the past few years, the market size for the foot and mouth disease vaccine has seen significant expansion. It is expected to rise from $2.61 billion in 2024 to $2.83 billion in 2025, at a compound annual growth rate (CAGR) of 8.6%. This growth during the historic period may be attributed to factors such as the development of multivalent vaccines, the widespread prevalence of foot and mouth disease, government efforts to control the disease, an emphasis on food safety, the economic consequences of FMD outbreaks, and investment in research and development.

What's the Projected Size of the Global Foot And Mouth Disease Vaccine Market by 2029?
In the coming years, the market size for the foot and mouth disease vaccine is anticipated to experience a swift expansion. By 2029, the market is projected to reach a valuation of $4.15 billion with a compound annual growth rate (CAGR) of 10.0%. The anticipated growth within the forecast period can be linked to factors such as the influence of climate change on disease proliferation, the emergence of new FMD variants, a holistic health approach, digital methods of vaccine distribution, significant improvements in the cold chain infrastructure for vaccines, ongoing enhancements in vaccine safety, integration with precise livestock farming, and international support for vaccination campaigns. Key market trends during this projected period include initiatives for global FMD elimination, the establishment of multivalent vaccines, collaborations between public and private entities, advancements in diagnostic and surveillance technologies, innovative biotechnological breakthroughs, genomic surveillance, and the integration of marker vaccines.

View the full report here:
https://www.thebusinessresearchcompany.com/report/foot-and-mouth-disease-vaccine-global-market-report

Top Growth Drivers in the Foot And Mouth Disease Vaccine Industry: What's Accelerating the Market?
The surge in the population of livestock is contributing to the expansion of the foot and mouth disease vaccine market. Livestock, farm animals such as cows, horses, and pigs that are kept, bred, and used by humans, are increasing in numbers due to heightened demand for animal-derived products. As the livestock numbers swell, there is a greater likelihood of the spread of foot and mouth disease, thereby boosting the market. For instance, a 2022 report from the US Department of Agriculture highlighted that India experienced a significant increase in its cattle herd, rising from 1.2 million in 2021 to 306.7 million in 2022. Hence, the expanding livestock population is set to fuel the foot and mouth disease vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8522&type=smp

What Trends Will Shape the Foot And Mouth Disease Vaccine Market Through 2029 and Beyond?
A major trend in the foot-and-mouth disease vaccine market is strategic alliances. The primary market participants are seeking partnership opportunities to utilize collective resources and venture into new markets. As an example, Biogénesis Bagó, an Argentina-based biotech firm specializing in foot-and-mouth disease vaccines, formed an alliance with FVC in July 2022 to establish an advanced FMD vaccine facility in South Korea. This strategic collaboration grants South Korea access to state-of-the-art technologies, allowing them to provide their domestic market with safe, superior quality FMD vaccines, create cost-effective options for local livestock farmers, and aid in maintaining the country's health status. FVC is an information technology services firm based in South Korea.

What Are the Main Segments in the Foot And Mouth Disease Vaccine Market?
The foot and mouth disease vaccine market covered in this report is segmented -

1) By Vaccine Type: Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines
2) By Animal Type: Cattle, Pig, Sheep And Goat, Other Animals
3) By Distribution Channel: Government Organizations, Distributors Or Pharmacies, Private Vet, Other Distribution Channels

Subsegments:
1) By Conventional Vaccines: Inactivated Whole Virus Vaccines, Live Attenuated Vaccines, Oil-Based Vaccines
2) By Oil-Based Vaccines: Oil Emulsion Vaccines, Oil Adjuvanted Vaccines, Aluminum Hydroxide OrSaponin Based Vaccines
3) By Aluminum Hydroxide Or Saponin Based Vaccines: Aluminum Hydroxide Adjuvanted Vaccines, Saponin Adjuvanted Vaccines
4) By Emergency Vaccines: DIVA (Differentiating Infected From Vaccinated Animals) Vaccines, Rapid Response Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8522&type=smp

Which Top Companies are Driving Growth in the Foot And Mouth Disease Vaccine Market?
Major companies operating in the foot and mouth disease vaccine market are Godrej Agrovet Limited, Biogénesis Bagó S.A., Indian Immunologicals Limited, Limor de Colombia, Merck & Co. Inc., Brilliant Bio Pharma Ltd., Intervet India Private Limited, Biovet Private Limited, China Animal Husbandry Group, C.H. Boehringer Sohn AG & Co. KG, VECOL S.A, VETAL Animal Health Products Inc., The Spirit Jinyu Biological Pharmaceutical Co. Ltd., Dong Bang Co. Ltd., FGBI‐ARRIAH, NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY, Ceva Santé Animale, MEVAC, Agrovet Market S.A., Alivira Animal Health Limited, Southern Cross Group, SPIC Gene Science Technology Development Co. Ltd., Zoetis Inc.

Which Regions Will Dominate the Foot And Mouth Disease Vaccine Market Through 2029?
Asia-Pacific was the largest region in the foot and mouth disease vaccine market in 2024. The regions covered in the foot and mouth disease vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8522

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach out to us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

The Business Research Company, with over 17,500+ reports across 27 industries and 60+ geographies, backed by 1,500,000 datasets and insights from industry leaders, offers comprehensive market intelligence through its flagship product, the Global Market Model (GMM), delivering updated forecasts for informed decision-making.

This release was published on openPR.